ENTITY

Chongkundang Holdings (001630 KS)

8
Analysis
Health Care • South Korea
Chongkundang Holdings Corporation operates as a holding company. The Company, through its subsidiaries, manufactures pharmaceutical products and medical drugs in the fields of systemic anti-infective, cardiovascular system, alimentary tract, metabolism, and sensory organs.
more
•27 Jan 2020 07:58

Impact of Coronavirus on 30 Key Korean Stocks

In this report, we compare the Coronavirus that is scaring the daylights of China and other countries around the world right now with the MERS...

Logo
512 Views
Share
•08 Dec 2016 08:24

MediSetter Interview: Insight on Opportunities in Asia's Healthcare Industry

Introduction to MedisetterI had the pleasure of interviewing Anirban Lahiri of Medisetter to discuss some of the opportunities present in Asia's...

Logo
4.1k Views
Share
•07 Jul 2016 00:13

SillaJen's December IPO: Valuation, Growth Expectation and IPO Timing

SillaJen Biotherapeutics (established in 2006) is indeed a rare breed in Korean pharmaceutical world. It is not a generic drug maker. It is not a...

Logo
3.6k Views
Share
x